Pfizer to halt development of closely watched weight-loss drug
Finances

Pfizer to halt development of closely watched weight-loss drug

[ad_1] Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Pfizer will halt its

Nasdaqpicks